Clinical trial

Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients

NCT00174343

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention exemestane (Aromasin®) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-11-01

PhasePHASE2

Conditions

Breast Neoplasmsunresolved

Interventions

exemestane (Aromasin®)DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

MontpellierFrance1 BordeauxFrance1 Clermont-FerrandFrance1 PoitiersFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00174343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.